Skip to main content
    C

    CERo Therapeutics Holdings, Inc. Common Stock (CERO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • PINK

    $0.00
    +0.00 (+0.00%)

    Market Cap: $358,150

    Last updated: Nov 16, 2026 at 4:00 PM ET

    CERo Therapeutics Holdings, Inc. Common Stock (CERO) Stock Chart

    Updated Nov 16, 2026. Prices from end-of-day market data; valuation figures from company filings.

    CERo Therapeutics Holdings, Inc. Common Stock (CERO) closed at $0.00 on Nov 16, 2026, 96.4% below its 52-week high of $0.14. Its price fell 95.1% over the past 12 months.

    Price Chart

    From Feb 2024 to Oct 2026, its highest month-end close was $6,140.00 in Mar 2024 and its lowest $0.00 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CERO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CERO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 56.4%, and over 6 months it fell 82.2%.

    PeriodChange
    1 month-20.0%
    3 months-56.4%
    6 months-82.2%
    12 months-95.1%
    12 months, with dividends-95.1%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$0.00-94.0%
    2025$0.07-99.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 38.5% below its 50-day average of $0.01 and 75.4% below its 200-day average of $0.02.

    MeasureValuePrice vs
    Close (Nov 16, 2026)$0.00
    52-week high$0.14-96.4%
    52-week low$0.00+60.0%
    50-day average$0.01-38.5%
    200-day average$0.02-75.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 100.0%.

    MeasureValue
    1-year beta1.27
    Largest fall, 1 year-97.1%
    Largest fall, 3 years-100.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CERO

    What is CERO's 1-year price change?

    CERo Therapeutics Holdings, Inc. Common Stock's price fell 95.1% over the past 12 months. With dividends included, the 12-month total return was -95.1%.

    What is CERO's 52-week high and low?

    CERo Therapeutics Holdings, Inc. Common Stock's 52-week high is $0.14 and its 52-week low is $0.00. Its close of $0.00 on Nov 16, 2026 is 96.4% below the high.

    What is CERO's beta?

    CERo Therapeutics Holdings, Inc. Common Stock's 1-year beta against the S&P 500 is 1.27, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 97.1%.

    Is the CERO chart free?

    Yes. Advanced Charting for CERO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.